Clinical and immunomodulatory effect of Fun-Boi, an herbal medicine, in rheumatoid arthritis

Journal of Clinical Rheumatology

Volumn 6, Issue 5, 2000, Pages 244-249

  Niizawa, A ^a   Kogure, T ^a   Fujinaga, H ^a   Takahashi, K ^a   Shimada, Y ^a   Terasawa, K ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Clinical study; Fun boi (Stephania tetrandra); Immunomodulation; Rheumatoid arthritis; Traditional herbal (Kampo) medicine

Indexed keywords

ANTIRHEUMATIC AGENT; CD3 ANTIGEN; CD8 ANTIGEN; FUNBOI; RHEUMATOID FACTOR; STEPHANIA TETRANDRA EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COUGHING; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HERBAL MEDICINE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; PAIN ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0033778857     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200010000-00003     Document Type: Article

References (44)

1. Long-term drug therapy for rheumatoid arthritis in seven Rheumatology private practices: II. Second line drugs and prednisone
2. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: A 14-year prospective evaluation of 1017 consecutive starts
3. Remodeling the pyramid: A concept whose time has come
4. The alkaloids of Han-Fang-Chi
5. Anti-inflammatory activity of the isoquinoline alkaloid, tetrandrine, against established adjuvant arthritis in rats
6. Tetrandrine inhibits signal-induced NF-kappa B activation in rat alveolar macrophages
7. Anti-inflammatory and immunosuppressive properties of the bis-benzylisoquinolines: In vitro comparisons of tetrandrine and berbamine
8. Inhibition of prostaglandin and leukotriene generation by the plant alkaloids tetrandrine and berbamine
9. Suppression of human monocyte interleukin 1 production by the plant alkaloid tetrandrine
10. Tetrandrine, a plant alkaloid, inhibits the production of tumor necrosis factor-alpha (cachectin) by human monocytes
11. In vitro immunosuppressive properties of the plant alkaloid tetrandrine
12. The effects of traditional antirheumatic herbal medicines on immune response cells
13. Selective inhibition of T-cell-dependent immune responses by bisbenzylisoquinoline alkaloids in vivo
14. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
15. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
16. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire
17. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures
18. The American Collage of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis
19. Leukocyte function-associated antigen 1 is an activation molecule for human T cells
20. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
21. Tetrandrine: A new ligand to block voltage-dependent Ca2+ and Ca (+)- activated K+ channels
22. A case of rheumatoid arthritis with a decrease in the serum concentration of soluble CD23 by traditional herbal medicine
23. The influence of a traditional herbal medicine on the disease activity in patients with rheumatoid arthritis
24. A case of mixed connective tissue disease with severe pulmonary fibrosis, which was treated with herbal drugs
25. A potential new treatment for rheumatoid arthritis: Thunder god vine
26. Peripheral blood T lymphocyte subpopulations determined by monoclonal antibodies in active rheumatoid arthritis
27. Determination of T lymphocyte subpopulations by monoclonal anti-bodies in rheumatoid arthritis: Influence of immunomodulating agents
28. Pathogenesis of rheumatoid arthritis and the development of rational drug therapy
29. Decrease in disease activity and concomitant increase in the percentage of peripheral blood suppressor T-cells in rheumatoid arthritis by a newly synthesized slow-acting anti-rheumatic drug (Bucillamine)
30. Enumeration of T-lymphocytes and T-lymphocyte subsets in rheumatoid arthritis using monoclonal antibodies
31. Detection of serum soluble markers of immune activation in rheumatoid arthritis
32. The immunoregulation of rheumatoid factor by the CD8 T lymphocyte subset in rheumatoid arthritis
33. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis: A controlled clinical trial
34. Low-dose D-penicillamine therapy in rheumatoid arthritis: A controlled, double-blind clinical trial
35. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis
36. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: A controlled clinical trial
37. Studies on the efficacy of unconventional therapies: Problems and designs
38. Bias in analytic research
39. Routine iron supplementation during pregnancy: Policy statement. US Preventive Services Task Force
40. Crossover and self-controlled designs in clinical research
41. Treatment of resistant rheumatoid arthritis with minocycline: An open study
42. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody
43. Low dose cyclosporine in rheumatoid arthritis: A pilot study
44. An open study of pentoxifylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis